公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2021 | Immunogenicity and Safety of AS03-adjuvanted H5N1 Influenza Vaccine in Children 6-35 Months of Age: Results from a Phase 2, Randomized, Observer-blind, Multicenter, Dose-ranging Study | Kim J.H.; Drame M.; Puthanakit T.; Chiu N.-C.; Supparatpinyo K.; LI-MIN HUANG ; Chiu C.-H.; Chen P.-Y.; Hwang K.-P.; Danier J.; Friel D.; Salaun B.; Woo W.; Vaughn D.W.; Innis B.; Schuind A. | Pediatric Infectious Disease Journal | 8 | 6 | |
2013 | A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 month of age | Pavia-Ruz N.; Weber M.A.R.; Lau Y.-L.; Nelson E.A.S.; Kerdpanich A.; LI-MIN HUANG ; Silas P.; Qaqundah P.; Blatter M.; Jeanfreau R.; Lei P.; Jain V.; El Idrissi M.; Feng Y.; Innis B.; Peeters M.; Devaster J.-M. | Human Vaccines and Immunotherapeutics | 17 | 17 |